LEXX: Lexaria Bioscience Corp. Stock

by  •  • Comments Off on LEXX: Lexaria Bioscience Corp. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 37.17
Enterprise Value ($M) 30.30
Book Value ($M) 7.66
Book Value / Share 0.44
Price / Book 4.85
NCAV ($M) 6.69
NCAV / Share 0.38
Price / NCAV 5.56

Profitability (mra)
Return on Invested Capital (ROIC) -0.74
Return on Assets (ROA) -1.88
Return on Equity (ROE) -2.16

Liquidity (mrq)
Quick Ratio 7.18
Current Ratio 7.18

Balance Sheet (mrq) ($M)
Current Assets 7.90
Assets 8.87
Liabilities 1.21
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.46
Operating Income -5.70
Net Income -5.80
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.96
Cash from Investing -0.19
Cash from Financing 10.32

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Invenomic Capital Management LP 4.70 -22.45
02-14 13D/A Boos Wayne W 4.67 6.67

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-01-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-27 26,064 87,417 29.82
2024-11-26 124,476 407,102 30.58
2024-11-25 29,624 120,897 24.50

(click for more detail)

Similar Companies
KRRO – Korro Bio, Inc. KTTA – Pasithea Therapeutics Corp.
KZR – Kezar Life Sciences, Inc. LFVN – LifeVantage Corporation
LGVN – Longeveron Inc.


Financial data and stock pages provided by
Fintel.io